Sagimet Biosciences Inc.
SGMTNasdaqCIK 1400118HealthcareFiscal year ends Dec 31
Reports and events: 77 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2211:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-428314 |
| 2026-10-0122:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-409335 |
| 2026-09-3010:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-408224 |
| 2026-08-1311:05 ET | 8-K | 8.01 Other events | 0001193125-26-347854 |
| 2026-08-1111:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-343446 |
| 2026-08-1111:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-343441 |
| 2026-07-2101:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-309334 |
| 2026-06-1220:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-26-073431 |
| 2026-06-0320:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-070126 |
| 2026-05-1211:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059009 |
| 2026-05-1211:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-059006 |
| 2026-04-2811:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-049756 |
| 2026-04-2711:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-049015 |
| 2026-04-2711:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-048971 |
| 2026-04-2120:11 ET | DEF 14A | Proxy statementPeriod 2026-06-12 | 0001104659-26-046006 |
| 2026-04-2110:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-26-045629 |
| 2026-03-1111:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-026146 |
| 2026-03-1111:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-026140 |
| 2026-02-0212:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-008925 |
| 2025-12-1812:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-122272 |
| 2025-12-1712:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-121819 |
| 2025-11-1312:36 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-110852 |
| 2025-11-1312:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-110846 |
| 2025-10-2320:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-101819 |
| 2025-08-2212:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-25-081630 |
| 2025-08-1421:02 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-078752 |
| 2025-08-1311:36 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-077200 |
| 2025-08-1311:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011301 |
| 2025-06-1021:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-25-058201 |
| 2025-06-0410:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-056160 |
| 2025-05-0810:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-045791 |
| 2025-05-0810:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006836 |
| 2025-04-3020:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-042566 |
| 2025-04-3020:26 ET | DEF 14A | Proxy statementPeriod 2025-06-09 | 0001104659-25-042560 |
| 2025-03-1211:35 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-022763 |
| 2025-03-1211:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002747 |
| 2025-03-1112:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-022423 |
| 2025-02-1421:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-014099 |
| 2025-01-0213:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-000137 |
| 2024-11-1413:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-118342 |
| 2024-11-1413:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015623 |
| 2024-08-1620:53 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-090546 |
| 2024-08-1412:06 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-089340 |
| 2024-08-1412:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-012136 |
| 2024-08-0112:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-084645 |
| 2024-07-0221:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-077430 |
| 2024-06-1310:07 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-071014 |
| 2024-06-0610:03 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-068817 |
| 2024-05-2311:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-064509 |
| 2024-05-1512:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-061609 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.